Morning all!

Premaitha Health ( Premaitha Health (LON:NIPT) ) – 8.25p – £31.9m – PER n/a

Trading Update For The 6 Months To End September 2018 – Revenues up 45% with a strong start to the second half of the year. Legal issue now settled and behind them, now focused on driving global growth.

Covering this stock for the first time because it popped up on my Tech Screen a month or so ago. This is a Loss maker that is not currently forecast to make a Profit (even on forecast double the Revenue seen in 2018A) so for this reason alone it has to go straight on my Avoid list for now.

Carclo ( Carclo (LON:CAR) ) – 86p – £63.1m – PER 7.19

Trading Update – H1 below the Board’s expectations but FY expectations are unchanged (H2 weighting!!!!!).

I am leaving this one on my Avoid list for now.

As always, all comment most welcome!

Finish reading with a 14 day trial

or Unlock with your email

Already have an account?
Login here